SHASTA-01

N/A

Report date: 2023/05/24 18:01:45

Base Information

Drug NameSHASTA-01
Drug Alias Nameanti-interleukin-18 binding protein antibodyanti-IL-18BP antibodySHASTA-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin 18 receptor inhibitors
TargetsInterleukin 18 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLassen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesLassen Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A